Metaphore Biotechnologies

United States - Cambridge, Massachusetts

• 18/05/2023
• Unknown
• $50,000,000

Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact.

Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.

Related People

Lovisa AfzeliusCo Founder

United States - Belmont, Massachusetts

Lovisa Afzelius is an origination partner at Flagship Pioneering. Lovisa has held or holds leadership positions such as CEO, co-founder, president, chairman of the board, and executive director across emerging biotech companies as well as large pharma. A computational scientist by training, she brings two decades of leadership experience and a passion for data-driven drug discovery, from early inception to clinical development across multiple therapeutic areas. Business delivery oriented, ambitious and highly motivated individual with excellent track-record of developing and executing complex strategic and operational plans across boundaries in a global matrix organization.

LinkedIn https://www.linkedin.com/in/lovisa-afzelius-9823628/